scholarly journals Polyp and cancer in the stomach and intestine.An advance of diagnosis and treatment.2.Pathophysiology of polyp and cancer in the stomach and intestine.2.Oncogene and carcinogenesis.Especially, occurrence and oncogene of colorectal cancer and tumor supressor gene.

1992 ◽  
Vol 81 (5) ◽  
pp. 643-648
Author(s):  
YOSHIHARU MAEDA
Metabolites ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 159
Author(s):  
Yao Peng ◽  
Yuqiang Nie ◽  
Jun Yu ◽  
Chi Chun Wong

Colorectal cancer (CRC) is one of the leading cancers that cause cancer-related deaths worldwide. The gut microbiota has been proved to show relevance with colorectal tumorigenesis through microbial metabolites. By decomposing various dietary residues in the intestinal tract, gut microbiota harvest energy and produce a variety of metabolites to affect the host physiology. However, some of these metabolites are oncogenic factors for CRC. With the advent of metabolomics technology, studies profiling microbiota-derived metabolites have greatly accelerated the progress in our understanding of the host-microbiota metabolism interactions in CRC. In this review, we briefly summarize the present metabolomics techniques in microbial metabolites researches and the mechanisms of microbial metabolites in CRC pathogenesis, furthermore, we discuss the potential clinical applications of microbial metabolites in cancer diagnosis and treatment.


2019 ◽  
Vol 59 ◽  
pp. 244-248 ◽  
Author(s):  
Eva Pozsgai ◽  
Csilla Busa ◽  
David Fodor ◽  
Szabolcs Bellyei ◽  
Agnes Csikos

JAMA ◽  
2021 ◽  
Vol 325 (7) ◽  
pp. 669
Author(s):  
Leah H. Biller ◽  
Deborah Schrag

1995 ◽  
pp. 56-62
Author(s):  
Brian P. Butler ◽  
Nishi P. Kuriyan ◽  
Raymond Rackley ◽  
Christine Campbell ◽  
Bryan R. G. Williams

Blood ◽  
1995 ◽  
Vol 86 (6) ◽  
pp. 2365-2370 ◽  
Author(s):  
K Offit ◽  
DC Louie ◽  
NZ Parsa ◽  
A Noy ◽  
RS Chaganti

Deletions of the long arm of chromosome 7, previously documented in myelodysplasias and myeloid leukemias, have also been noted in lymphoid malignancies. Of 558 karyotypically abnormal specimens of non-Hodgkin's lymphoma (NHL) serially ascertained over an 8-year period, del(7q) was identified in 24 cases, 10 of which were of the small lymphocytic (sm lym) subtype. Del(7q) was the third most common karyotypic abnormality among the cohort of 61 sm lym cases in this ascertainment. Mapping of the deletions identified a region of common deletion affecting 7q32, which was the sole karyotypic abnormality in 2 cases. Eight of the ten sm lym cases were characterized by plasmacytoid features in histologic sections of lymphoma tumors or circulating cells in the peripheral blood. The del(7)(q32) was accompanied by 14q32-associated translocations in 11 of the 14 cases with histologies other than sm lym, compared with 2 of the sm lym cases. Extranodal involvement was more frequent in the del(7)(q32) sm lym NHLs, although median survival was typical of other low-grade lymphomas. These results suggest that loss or inactivation of a putative tumor-supressor gene at 7q32 may play a role the progression of lymphomas as well as constitute an early event in the pathogenesis of lymphoplasmacytoid tumors.


1987 ◽  
Vol 4 (3) ◽  
pp. 147-155
Author(s):  
Takayoshi Tobe ◽  
S. Maetani ◽  
T. Nishikawa ◽  
T. Nagai ◽  
Y. Iijima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document